Research Initiative/Treatment Action! - LAMIVUDINE
March 1, 2000 -- Lamivudine tablets are film-coated, white, and diamond-shaped with the dosage "150" imprinted on one side and "GX CJ7" on the...
Skin & Allergy News - Entecavir vs. lamivudine for HBV
May 1, 2006 -- Two head-to-head phase III trials have shown that the new drug entecavir may be superior to lamivudine for treating chronic hepatitis B. The two...
Internal Medicine News - Entecavir vs. lamivudine for HBV
April 15, 2006 -- Two head-to-head phase III trials have shown that the new drug entecavir may be superior to lamivudine for treating chronic hepatitis B. The two...
Internal Medicine News - Telbivudine tops lamivudine for HBV at 2 years
February 15, 2007 -- BOSTON -- Telbivudine showed greater efficacy than lamivudine did during 2 years of treatment for chronic hepatitis B infection, according to the...
CME: Your SA Journal of CPD - Once-daily dosage lamivudine another ARV first for Cipla Medpro
February 1, 2008 -- In an effort to promote adherence to medication and offer convenience to many people living with HIV/AIDS, local pharmaceutical company Cipla Medpro...
Internal Medicine News - Lamivudine is still useful against some hepatitis B
October 1, 2006 -- SOUTH LAKE TAHOE, CALIF. -- Lamivudine and interferon alfa still have independent roles to play in treating some patients with chronic hepatitis B,...
American Family Physician - Lamivudine for hepatitis B with advanced fibrosis
February 15, 2005 -- Clinical Question: Is lamivudine safe and effective for the treatment of hepatitis B infection in patients with advanced liver disease? Setting:...
Journal of AOAC International - Quantitative determination and sampling of lamivudine and zidovudine residues for cleaning validation in a production area
May 1, 2007 -- Lamivudine (3TC) and zidovudine (AZT) are systemic antiviral substances extensively used in human immunodeficiency virus (HIV) infected patients....
Pediatric News - Lamivudine vs. placebo for HBV
July 1, 2002 -- Lamivudine is a safe and effective treatment for chronic hepatitis B infection in children, said Dr. Maureen M. Jonas of Children's Hospital, Boston,...
Business Wire - Research and Markets: Generics Company Cipla Claims to Have Been the First Local Manufacturer to Introduce a Number of Products to the Indian Market, Including...
May 19, 2007 -- DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c45980) has announced the addition of Cipla Generics Company...
